Finance

Beta
Lists
GPCR:NASDAQ
Structure Therapeutics Inc
$44.51
-1.09%
(-0.49) 1D
$44.51
0.00% (0.00)
After hours
Closed: Jun 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GPCR...
Open
$45.94
High
$47.24
Low
$44.35
Mkt. cap
3.16B
Avg. vol.
744.46K
Volume
1.15M
52-wk high
$94.90
52-wk low
$15.80
EPS
-$2.72
Beta
-1.43
Shares outstanding
71.07M
No. of employees
233
Open
$45.94
High
$47.24
Low
$44.35
Mkt. cap
3.16B
Avg. vol.
744.46K
Volume
1.15M
52-wk high
$94.90
52-wk low
$15.80
EPS
-$2.72
Beta
-1.43
Shares outstanding
71.07M
No. of employees
233
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to GPCR in the past 3 months
Strong Buy
Buy
8
Hold
0
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for GPCR in the last 3 months.
Highest
Current $44.51
$145.00 (+225.77%)
Average
$110.17 (+147.52%)
Lowest
$70.00 (+57.27%)
News stories
From sources across the web
About Structure Therapeutics Inc
CEO-
Employees233
Founded2016
HeadquartersSouth San Francisco, California, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
54.71M
58.99M
68.69M
66.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.74M
14.80M
17.57M
22.87M
Operating expense
70.45M
73.79M
-13.74M
89.38M
Total operating expenses
70.45M
73.79M
-13.74M
89.38M
Operating income
-70.45M
-73.79M
13.74M
-89.38M
Other non operating income
-
-
-13.86M
-
EBT including unusual items
-61.52M
-65.60M
33.17M
-75.78M
EBT excluding unusual items
-61.52M
-65.60M
35.75M
-75.78M
Income tax expense
139.00K
108.00K
170.00K
190.00K
Effective tax rate
-0.23%
-0.16%
0.51%
-0.25%
Other operating expenses
-
-
-100.00M
-
Net income
-61.66M
-65.71M
33.00M
-75.97M
Net profit margin
-
-
-
-
Earnings per share
-0.36
-0.37
-0.46
-0.35
Interest and investment income
8.93M
8.18M
35.87M
13.60M
Interest expense
-
-
-
-
Net interest expenses
8.93M
8.18M
35.87M
13.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
-70.16M
-73.41M
14.47M
-88.79M
Gain or loss from assets sale
-
-
-10.25M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more